Pancreatic Cancer Research

ResearcherUniversity of PittsburghActive in the last 2 years

Sebastiaan Ceuppens

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0001-8628-1987; OpenAlex author ID A5028954030, A5152788475. Sources: OpenAlex.

Their work

Papers
10 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
31
Papers, trials and grants by year

2025: 3 papers · 2026: 7 papers

Papers 10

  1. Pretreatment CA19-9 Predicts Survival in Pancreatic Cancer With Optimal Response to Neoadjuvant Therapy. Co-author DOI 10.1002/jso.70179↗
  2. Pancreatic Cancer Organoids Recapitulate Chemotherapy Response and Identify a Potent Cytotoxic T-Cell Population. Co-author DOI 10.1158/1078-0432.ccr-25-1110↗
  3. Liquid Biopsy in Resected Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis. First author DOI 10.1245/s10434-026-20413-w↗
  4. ASO Visual Abstract: Liquid Biopsy in Resected Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-analysis. First author DOI 10.1245/s10434-026-20555-x↗
  5. ASO Author Reflections: Liquid Biopsy in Resected Pancreatic Ductal Adenocarcinoma-From Prognostic Association to Clinical Utility. Co-author DOI 10.1245/s10434-026-20585-5↗
  6. Evaluation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Localized Pancreatic Cancer: Trans-Atlantic Pancreatic Surgery Consorti… Co-author DOI 10.1245/s10434-026-20620-5↗
  7. ASO Visual Abstract: Evaluation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Localized Pancreatic Cancer: Trans-Atlantic Pancre… Co-author DOI 10.1245/s10434-026-20742-w↗
  8. Implications of an Isolated Positive Vascular Groove After Whipple for Pancreatic Adenocarcinoma: A Single Institution, Retrospective Analysis. First author DOI 10.1002/jso.70052↗
  9. Optimizing Perioperative Management of Pancreatic Ductal Adenocarcinoma: Insights Into Modified FOLFIRINOX Relative Dose Intensity and CA 19-9 Dynamics. Co-author DOI 10.1002/jso.70057↗
  10. Survival prediction for CA19-9 non-producers with resected pancreatic cancer. Co-author DOI 10.1016/j.hpb.2025.05.007↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Alessandro Paniccia · 10 shared papers, 2025–2026 · strength 2.87
  2. Amer H. Zureikat · 9 shared papers, 2025–2026 · strength 2.37
  3. Jiage Qian · 6 shared papers, 2025–2026 · strength 1.83
  4. Bas Groot Koerkamp · 4 shared papers, 2026 · strength 1.14
  5. Aatur Dilip Singhi · 3 shared papers, 2025–2026 · strength 0.75
  6. Asmita Chopra · 3 shared papers, 2025–2026 · strength 0.73
  7. Siyang Zheng · 2 shared papers, 2026 · strength 0.60
  8. Matthew H. G. Katz · 2 shared papers, 2026 · strength 0.54
  9. Esther N. Dekker · 2 shared papers, 2026 · strength 0.54
  10. Jun Okui · 2 shared papers, 2026 · strength 0.54
  11. Eileen Mary O'Reilly · 2 shared papers, 2026 · strength 0.54
  12. Naruhiko Ikoma · 2 shared papers, 2026 · strength 0.54
  13. Marc G. Besselink · 2 shared papers, 2026 · strength 0.54
  14. Ching-Wei David Tzeng · 2 shared papers, 2026 · strength 0.54
  15. Alice Chia-Chi Wei · 2 shared papers, 2026 · strength 0.54
  16. Pranav Murthy · 1 shared paper, 2026 · strength 0.26
  17. Renee R. Anderko · 1 shared paper, 2026 · strength 0.26
  18. Michael T. Lotze · 1 shared paper, 2026 · strength 0.26
  19. Callie A. Hlavin · 1 shared paper, 2025 · strength 0.25
  20. Ibrahim Nassour · 1 shared paper, 2025 · strength 0.25
  21. Anwaar Saeed · 1 shared paper, 2025 · strength 0.25
  22. Jurgis Alvikas · 1 shared paper, 2025 · strength 0.24
  23. Genia Dubrovsky · 1 shared paper, 2025 · strength 0.24
  24. Melissa Ellen Hogg · 1 shared paper, 2026 · strength 0.23
  25. Sarah B. Hays · 1 shared paper, 2026 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.